OR WAIT null SECS
June 17, 2010
GSK Acquires Laboratorios Phoenix; Catalent Makes Executive Appointments; And More.
June 03, 2010
Thermo Fisher to Acquire Fermentas; Pfizer Names Head of R&D; And More.
June 02, 2010
Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.
Too much or too little control can actually lead to the same result.
May 27, 2010
Bayer to Open San Francisco Innovation Hub; Lonza Bioscience Names COO; And More.
May 20, 2010
Lonza Acquires MODA; Sigma-Aldrich Exec to Retire; And More.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) published its "Ten Principles on Counterfeit Medicines" last week to draw public attention to the issue.
May 13, 2010
Effective May 1, 2010, the US Pharmacopeia has revised its Pending Monographs Guideline to clarify that excipients are eligible for pending-monograph status and can ultimately be included in an official National Formulary (NF) monograph.
In an effort to standardize quality agreements for active pharmaceutical ingredients in the drug industry, the Bulk Pharmaceuticals Task Force, an affiliate of the Society of Chemical Manufacturers and Affiliates, has developed a template to help manufacturers and customers comply with US regulatory requirements in a simplified manner.
Week Of May 10, 2010: Company And People Notes: Ariad and Merck Restructure Collaboration; Genzyme Changes Leadership; and More